Clinical trial Recruiting at 1 site Interventional Ages 0 Hours to 3 Days

Video-guided vs direct laryngoscopy for less invasive surfactant delivery in extremely preterm infants

Official title: Randomized Controlled Trial of Video-Laryngoscopy Intervention or Direct Laryngoscopy for Delivery of Less Invasive Surfactant Administration for Premature Infants

Run by University of Texas Southwestern Medical Center · NCT07426016 · Data updated 2026-11-12

This trial tests whether using video laryngoscopy helps give surfactant on the first try more often than direct laryngoscopy in extremely preterm babies needing surfactant.

Quick facts

Study typeInterventional
Ages0 Hours to 3 Days
SexAll
Enrollment100 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Locations1 site (Dallas, Texas)
StatusRecruiting
StartedJune 11, 2026
Main results expectedJune 2028
Study endsNovember 2028
Registry record updatedJune 15, 2026
Trial IDNCT07426016 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants born at ≤28 weeks' gestation, successfully resuscitated in the delivery room and on CPAP who need surfactant within the first 36 hours.

Probably not a fit

Infants born ≥29 weeks, those with congenital anomalies, those receiving comfort care only, or those already intubated before surfactant may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two visualization methods during less invasive surfactant administration in neonates born at or before 28 weeks gestation. The goal is to see if video laryngoscopy improves first-attempt success compared with direct laryngoscopy, and to describe potential benefits of each approach. Eligible infants are those resuscitated in the delivery room, on CPAP, and requiring surfactant within 36 hours of life. Exclusions include infants born after 28 weeks, with major congenital anomalies, those receiving comfort care, or those intubated before surfactant. The study is led by University of Texas Southwestern Medical Center at Parkland Hospital in Dallas, Texas.

Why it matters

Potential benefit: If successful, the method that achieves higher first-try surfactant delivery could reduce procedural time and potential lung injury.

How similar studies have gone: Previous research in neonatal airway management supports benefits of visualization aids, but this specific direct comparison in LISA is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Infants born ≤28 weeks GA successfully resuscitated in the delivery room (DR) and maintained on CPAP • Need for surfactant in the first 36 hours of life based on clinical assessment and/or meeting threshold per unit protocol

Exclusion Criteria:

* Infants born ≥29 weeks GA or
* Infants with known congenital anomalies or
* Infants who are determined by the primary care team to receive comfort care only or
* Infants who are intubated at any time prior to surfactant administration

Where it's running

  • Parkland Hospital
    Dallas, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.